Varicella vaccine update committee on infectious diseases

Pediatrics

Volumn 105, Issue 1 II, 2000, Pages 136-141

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748555944     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics. 1995;95:791-796
2. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45(RR-ll):l-36
3. Centers for Disease Control and Prevention. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1999;48(RR-6):l-5
4. Centers for Disease Control and Prevention. Varicella-related deaths among adults: United States, 1997. MMWR Morb Mortal Wkly Rep. 1997;46:409-412
5. Centers for Disease Control and Prevention. Varicella-related deaths among children: United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47:365-368
6. Immunizations and infectious diseases. In: Healthy People 2010 Objectives: Draft for Public Comment. Bethesda, MD: US Dept of Health and Human Services, Office of Public Health and Science; September 15, 1998:22-1 to 22-36
7. Chew D, Hofmann J, O'Donnell C, Finelli L. Physician attitudes and practices regarding varicella vaccine in New Jersey. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996; Washington, DC. K158
8. Centers for Disease Control and Prevention. Outbreak of invasive group A Streptococcus associated with varicella in a childcare center: Boston, Massachusetts, 1997. MMWR Morb Mortal Wkly Rep. 1997;46:944-948
9. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Met}. 1996;335:547-554
10. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996;10:571-581
11. Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections. J Pediatr. 1997;130:759-765
12. Finger R, Hughes JP, Meade BJ, Pelletier AR, Pakner CT. Age-specific incidence of chickenpox. Public Health Rep. 1994;109:750-755
13. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991;9:643-647
14. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella vaccine: efficacy trial in healthy children. N Ettgl J Med. 1984;310:1409-1415
15. Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA. 1997;278: 1495-1499
16. Shapiro ED, LaRussa PS, Steinberg SP, Gershon AA. Protective efficacy of varicella vaccine. In: Program and abstracts of the 36th Annual Meeting of the Infectious Diseases Society of America; Denver, CO; November 12-15, 1998. 78
17. Tabony L, Kilgore P, Pelosi J, et al. Varicella vaccine effectiveness during a child care center outbreak, Travis County, Texas, 1998. In: Program and abstracts of the 36th Annual Meeting of the Infectious Diseases Society of America; Denver, CO; November 12-15, 1998. Abstract 79
18. Clements DA. Modified varicella-like syndrome. Infect Dis Clin North Am. 1996;10:617-629
19. Asano Y, Suga S, Yashikawa T, et al. Experience and reason: twentyyear follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994;94:524-526
20. Johnson CE, Stancin T, Fattlar D, Rome UP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics. 1997;100:761-766
21. Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994;140: 81-104
22. Plotkin SA. Varicella vaccine. Pediatrics. 1996;97:251-253
23. Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271:375-381
24. Huse DM, Meissner HC, Lacey MJ, Oster G. Childhood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr. 1994;124: 869-874
25. Beutels P, Clara R, Tormans G, Van Doorslaer E, Van Damme P. Costs and benefits of routine varicella vaccination in German children. J Infect Dis. 1996;174(suppl 3):S335-S341
26. Asano Y, Nakayama H, Yazaki T, Ito S, Isomura S, Takahashi M. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics. 1977;59:8-12
27. Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics. 1977;59:3-7
28. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986;78:748-756
29. Salzman MB, Garcia C. Postexposure varicella vaccination in siblings of children with active varicella. Pediatr Infect Dis J. 1998;17:256-257
30. Lieu TA, Black SB, Takahashi H, et al. Varicella serology among school age children with a negative or uncertain history of chickenpox. Pediatr Infect Dis }. 1998;17:120-125
31. Feder HM Jr, La Russa P, Steinberg S, Gershon AA. Clinical varicella following varicella vaccination: don't be fooled. Pediatrics. 1997;99: 897-899
32. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella vaccine: efficacy trial in healthy children. N Engl J Med. 1984;310:1409-1415
33. Guess HA, Broughton DD, Melton LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics. 1986;78:723-727
34. Salzman MB, Sharrar RG, Steinberg S, La Russa P. Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr. 1997;131:151-154